Recombinant activated protein C in pediatric sepsis

Journal article

Peer reviewed

Pediatric Infectious Disease Journal, Vol.22(8)

2003

Abstract

activated protein C

drotrecogin

placebo

bleeding

cause of death

child

child hospitalization

childhood mortality

clinical feature

clinical trial

dose response

drug blood level

drug fatality

drug safety

human

pathogenesis

priority journal

protein C deficiency

risk benefit analysis

sepsis

short survey

survival

treatment outcome

1 Record Views